We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Sorrento's TNK Therapeutics Subsidiary to Acquire Virttu Biologics

News   Nov 24, 2016

 
Sorrento's TNK Therapeutics Subsidiary to Acquire Virttu Biologics
 
 
 

RELATED ARTICLES

Circulating Tumor Cell Clusters Identified in Head and Neck Cancer Patients

News

Australian study demonstrates the importance of detecting circulating tumor cell clusters using microfluidic technology.

READ MORE

Blood Test Could Identify Women at Risk for Gestational Diabetes

News

Early screening could allow for lifestyle changes before gestational diabetes develops.

READ MORE

Zika Vaccine Clinical Trial Begins

News

Vaccinations have begun in a first-in-human trial of an experimental live, attenuated Zika virus vaccine.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Diagnostics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE